Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy–obstacles and perspectives

J Procházková, Z Kahounová, J Vondráček… - …, 2024 - Taylor & Francis
Aryl hydrocarbon receptor (AhR) is a transcription factor that is primarily known as an
intracellular sensor of environmental pollution. After five decades, the list of synthetic and …

Liquid biopsy: from concept to clinical application

C Alix-Panabières, D Marchetti, JE Lang - Scientific Reports, 2023 - nature.com
The diagnosis and treatment of cancer presents a physical and mental burden to the patient,
often involving diagnostic biopsies and surgeries or chemotherapeutic approaches with …

Trop2-Targeted Molecular Imaging in Solid Tumors: Current Advances and Future Outlook

Y Liu, W Huang, RJ Saladin, JC Hsu… - Molecular …, 2024 - ACS Publications
Trophoblast cell surface antigen 2 (Trop2), a transmembrane glycoprotein, plays a dual role
in physiological and pathological processes. In healthy tissues, Trop2 facilitates …

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

S Liu, SJ Hawley, CA Kunder, EC Hsu, M Shen… - Scientific reports, 2024 - nature.com
Distinguishing indolent from clinically significant localized prostate cancer is a major clinical
challenge and influences clinical decision-making between treatment and active …

[PDF][PDF] Targeting Trop-2 as a Cancer Driver

E Guerra, M Trerotola, S Alberti - Journal of Clinical Oncology, 2023 - ricerca.unich.it
The Trop-2–targeting antibody-drug conjugate (ADC) sacituzumab govitecan (SG) has been
approved by the US Food and Drug Administration and European Medicines Agency for …

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates

A Ajkunic, E Sayar, MP Roudier, RA Patel… - npj Precision …, 2024 - nature.com
Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as
an important strategy for precision oncology. To capitalize on the potential impact of drugs …

[HTML][HTML] Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma

M Chen, Y Gao, H Cao, Z Wang, S Zhang - Heliyon, 2024 - cell.com
Background Epithelial cell adhesion molecule (EpCAM), a well-established marker for
circulating tumor cells, plays a crucial role in the complex process of cancer metastasis. The …

Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape

C Yang, L Wang, C Gong, D Lv, H Li… - Oncology …, 2025 - spandidos-publications.com
The global incidence of prostate cancer (PCa) is rising. Localized PCa can be managed
through surgical intervention or radiotherapy, but certain patients may experience …

Immunotherapy combinations for metastatic castration-resistant prostate cancer–failed trials and future aspects

SF Slovin - Current Opinion in Urology, 2023 - journals.lww.com
Immunotherapy with checkpoint inhibitors alone or in combination with a variety of agents
such as chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors or novel biologics …

[HTML][HTML] Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates

A Ajkunic, E Sayar, MP Roudier, RA Patel… - Research …, 2023 - ncbi.nlm.nih.gov
Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as
an important strategy for precision oncology. To fully capitalize on the potential impact of …